Armando Tripodi
#122,817
Most Influential Person Now
Researcher
Armando Tripodi's AcademicInfluence.com Rankings
Armando Tripodicomputer-science Degrees
Computer Science
#5019
World Rank
#5304
Historical Rank
Computational Linguistics
#601
World Rank
#613
Historical Rank
Machine Learning
#1177
World Rank
#1197
Historical Rank
Artificial Intelligence
#1409
World Rank
#1438
Historical Rank
Download Badge
Computer Science
Armando Tripodi's Degrees
- PhD Computer Science Stanford University
- Masters Computer Science University of California, Berkeley
Similar Degrees You Can Earn
Why Is Armando Tripodi Influential?
(Suggest an Edit or Addition)Armando Tripodi's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Update of the guidelines for lupus anticoagulant detection (2009) (1111)
- Hypercoagulability of COVID‐19 patients in intensive care unit: A report of thromboelastography findings and other parameters of hemostasis (2020) (1079)
- The coagulopathy of chronic liver disease. (2011) (925)
- Evidence of normal thrombin generation in cirrhosis despite abnormal conventional coagulation tests (2005) (632)
- D-dimer testing to determine the duration of anticoagulation therapy. (2006) (527)
- EASL Clinical Practice Guidelines: Vascular diseases of the liver. (2016) (511)
- An imbalance of pro- vs anti-coagulation factors in plasma from patients with cirrhosis. (2009) (499)
- Coagulation disorders and hemostasis in liver disease: Pathophysiology and critical assessment of current management (2006) (466)
- Thrombin generation in patients with cirrhosis: The role of platelets (2006) (361)
- Hemostasis and thrombosis in patients with liver disease: the ups and downs. (2010) (324)
- COVID-19 and haemostasis: a position paper from Italian Society on Thrombosis and Haemostasis (SISET). (2020) (286)
- Hypercoagulability in cirrhosis: causes and consequences 1 (2011) (261)
- Measuring oral direct inhibitors of thrombin and factor Xa: a recommendation from the Subcommittee on Control of Anticoagulation of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis (2013) (257)
- The Coagulopathy of Chronic Liver Disease (2012) (240)
- Thrombin Generation Assay and Its Application in the Clinical Laboratory. (2016) (214)
- Severe hemophilia with mild bleeding phenotype: molecular characterization and global coagulation profile (2010) (192)
- A shortened activated partial thromboplastin time is associated with the risk of venous thromboembolism. (2004) (189)
- The international normalized ratio calibrated for cirrhosis (INRliver) normalizes prothrombin time results for model for end‐stage liver disease calculation (2007) (187)
- Thrombin generation assessed as endogenous thrombin potential in patients with hyper- or hypo-coagulability. (2003) (180)
- High thrombin generation measured in the presence of thrombomodulin is associated with an increased risk of recurrent venous thromboembolism (2008) (178)
- Abnormalities of hemostasis in chronic liver disease: reappraisal of their clinical significance and need for clinical and laboratory research. (2007) (177)
- Review article: the prothrombin time test as a measure of bleeding risk and prognosis in liver disease (2007) (174)
- Questions and answers on the use of dabigatran and perspectives on the use of other new oral anticoagulants in patients with atrial fibrillation. A consensus document of the Italian Federation of Thrombosis Centers (FCSA). (2011) (170)
- Diagnosis, Development, and Treatment of Portal Vein Thrombosis in Patients With and Without Cirrhosis. (2019) (165)
- Testing for Antiphospholipid antibodies with Solid Phase Assays: guidance from the SSC of the ISTH (2014) (165)
- Evidence that low protein C contributes to the procoagulant imbalance in cirrhosis. (2013) (161)
- Clinical Manifestations and Management of Inherited Thrombophilia: Retrospective Analysis and Follow-up after Diagnosis of 238 Patients with Congenital Deficiency of Antithrombin III, Protein C, Protein S (1994) (161)
- The coagulopathy of cirrhosis assessed by thromboelastometry and its correlation with conventional coagulation parameters. (2008) (159)
- Risk of venous thromboembolism and clinical manifestations in carriers of antithrombin, protein C, protein S deficiency, or activated protein C resistance: a multicenter collaborative family study. (1999) (150)
- Changing Concepts of Cirrhotic Coagulopathy (2017) (148)
- Usefulness of repeated D-dimer testing after stopping anticoagulation for a first episode of unprovoked venous thromboembolism: the PROLONG II prospective study. (2010) (147)
- Detection of the imbalance of procoagulant versus anticoagulant factors in cirrhosis by a simple laboratory method (2010) (140)
- Hypercoagulability in patients with type 2 diabetes mellitus detected by a thrombin generation assay (2011) (135)
- Laboratory investigation of thrombophilia. (2001) (132)
- Plasma levels of direct oral anticoagulants in real life patients with atrial fibrillation: Results observed in four anticoagulation clinics. (2016) (131)
- The International Normalized Ratio calibrated for rivaroxaban has the potential to normalize prothrombin time results for rivaroxaban‐treated patients: results of an in vitro study (2011) (130)
- An international multicenter randomized study of computer‐assisted oral anticoagulant dosage vs. medical staff dosage (2008) (126)
- Classification of rare bleeding disorders (RBDs) based on the association between coagulant factor activity and clinical bleeding severity (2012) (123)
- D-dimer testing in laboratory practice. (2011) (122)
- Acquired coagulation disorders: revisited using global coagulation/anticoagulation testing (2009) (119)
- Thrombosis during Pregnancy and Surgery in Patients with Congenital Deficiency of Antithrombin III, Protein C, Protein S (1994) (116)
- Global hemostasis tests in patients with cirrhosis before and after prophylactic platelet transfusion (2013) (114)
- Antiphospholipid syndrome: laboratory detection, mechanisms of action and treatment (2011) (112)
- Are Capillary Whole Blood Coagulation Monitors Suitable for the Control of Oral Anticoagulant Treatment by the International Normalized Ratio? (1993) (111)
- Survey of lupus anticoagulant diagnosis by central evaluation of positive plasma samples (2007) (110)
- Guidance from the Scientific and Standardization Committee for lupus anticoagulant/antiphospholipid antibodies of the International Society on Thrombosis and Haemostasis (2020) (109)
- Low drug levels and thrombotic complications in high‐risk atrial fibrillation patients treated with direct oral anticoagulants (2018) (107)
- Procoagulant imbalance in patients with non-alcoholic fatty liver disease. (2014) (103)
- Laboratory control of oral anticoagulant treatment by the INR system in patients with the antiphospholipid syndrome and lupus anticoagulant. Results of a collaborative study involving nine commercial thromboplastins (2001) (100)
- Markers of Procoagulant Imbalance in Patients with Inherited Thrombophilic Syndromes (1992) (98)
- Circulating microparticles and risk of venous thromboembolism. (2009) (97)
- The laboratory and the direct oral anticoagulants. (2013) (95)
- Thrombin generation in plasma from patients with cirrhosis supplemented with normal plasma: considerations on the efficacy of treatment with fresh-frozen plasma (2012) (94)
- Measurement of von Willebrand factor cleaving protease (ADAMTS‐13): results of an international collaborative study involving 11 methods testing the same set of coded plasmas (2004) (92)
- Laboratory Screening of Inherited Thrombotic Syndromes (1987) (85)
- Effect of tamoxifen on measurements of hemostasis in healthy women. (1996) (83)
- Hyperprothrombinemia associated with prothrombin G20210A mutation inhibits plasma fibrinolysis through a TAFI-mediated mechanism. (2004) (82)
- Procoagulant imbalance in patients with non-alcoholic fatty liver disease. (2014) (82)
- Effects of inhalable particulate matter on blood coagulation (2010) (80)
- Antiphospholipid antibody ELISAs: survey on the performance of clinical laboratories assessed by using lyophilized affinity-purified IgG with anticardiolipin and anti-beta2-Glycoprotein I activity. (2007) (78)
- Unbalanced oxidative status in idiopathic sudden sensorineural hearing loss (2012) (78)
- Lupus anticoagulant (LA) testing: performance of clinical laboratories assessed by a national survey using lyophilized affinity-purified immunoglobulin with LA activity. (2003) (75)
- The laboratory and the new oral anticoagulants. (2013) (73)
- Screening for the FV: Q506 Mutation – Evaluation of Thirteen Plasma-based Methods for their Diagnostic Efficacy in Comparison with DNA Analysis (1997) (73)
- Hypercoagulability in splenectomized thalassemic patients detected by whole-blood thromboelastometry, but not by thrombin generation in platelet-poor plasma (2009) (73)
- The endogenous thrombin potential and the risk of venous thromboembolism. (2007) (72)
- Laboratory testing for lupus anticoagulants: a review of issues affecting results. (2007) (72)
- European Concerted Action on Anticoagulation (2002) (70)
- Laboratory Diagnosis of Lupus Anticoagulants for Patients on Oral Anticoagulant Treatment (2002) (69)
- Normal thrombin generation in neonates in spite of prolonged conventional coagulation tests (2008) (69)
- Abnormalities of hemostasis and bleeding in chronic liver disease: the paradigm is challenged (2010) (68)
- The International Normalized Ratio (INR) in the MELD Score: Problems and Solutions (2010) (67)
- Tests of coagulation in liver disease. (2009) (64)
- Poor comparability of coagulation screening test with specific measurement in patients receiving direct oral anticoagulants: results from a multicenter/multiplatform study (2016) (64)
- World Health Organization (WHO) Guidelines for thromboplastins and plasma used to control oral anticoagulant therapy (1999) (63)
- A multicentre randomised assessment of the DAWN AC computer-assisted oral anticoagulant dosage program (2009) (63)
- Treatment of congenital antithrombin III deficiency with concentrates (1982) (62)
- Drug levels and bleeding complications in atrial fibrillation patients treated with direct oral anticoagulants (2019) (61)
- Increased thrombin generation in inflammatory bowel diseases. (2008) (60)
- Silica clotting time (SCT) as a screening and confirmatory test for detection of the lupus anticoagulants. (1992) (60)
- Reliability of international normalised ratios from two point of care test systems: comparison with conventional methods (2003) (59)
- Second international collaborative study evaluating performance characteristics of methods measuring the von Willebrand factor cleaving protease (ADAMTS‐13) (2008) (58)
- Hemostatic balance in patients with liver cirrhosis: Report of a consensus conference. (2016) (58)
- A prothrombin time-based functional assay of protein S. (1990) (58)
- Fresh frozen plasma transfusion in patients with cirrhosis and coagulopathy: effect on conventional coagulation tests and thrombomodulin-modified thrombin generation. (2019) (57)
- Hemostasis abnormalities in cirrhosis (2015) (55)
- Guidelines on preparation, certification, and use of certified plasmas for ISI calibration and INR determination (2004) (54)
- Fibrinogen assays: a collaborative study of six different methods. C.I.S.M.E.L. Comitato Italiano per la Standardizzazione dei Metodi in Ematologia e Laboratorio. (1991) (54)
- International Collaborative Study for the Calibration of a Proposed Reference Preparation for Thromboplastin, Human Recombinant, Plain (1998) (53)
- Harmful and Beneficial Effects of Anticoagulants in Patients With Cirrhosis and Portal Vein Thrombosis (2017) (53)
- Position Paper on laboratory testing for patients on direct oral anticoagulants. A Consensus Document from the SISET, FCSA, SIBioC and SIPMeL. (2018) (53)
- International Survey on D-Dimer Test Reporting: A Call for Standardization (2015) (53)
- Near‐patient testing devices to monitor oral anticoagulant therapy (2001) (52)
- Hemostatic defects in liver and renal dysfunction. (2012) (52)
- Multicenter Study of Homocysteine Measurement – Performance Characteristics of Different Methods, Influence of Standards on Interlaboratory Agreement of Results (2001) (52)
- A comparison of lupus anticoagulant-positive patients with clinical picture of antiphospholipid syndrome and those without. (2007) (52)
- Protein S Deficiency Associated with “Juvenile” Arterial and Venous Thromboses (1986) (51)
- Familial Dysfunction of Protein S (1989) (51)
- Multicentric Evaluation of a New Assay for Prothrombin Fragment F1+2 Determination (1992) (51)
- Anti-phosphatidylserine/prothrombin antibodies: an additional diagnostic marker for APS? (2013) (51)
- Resistance to thrombomodulin is associated with de novo portal vein thrombosis and low survival in patients with cirrhosis (2016) (51)
- Hemostasis changes during veno-venous extracorporeal membrane oxygenation for respiratory support in adults. (2016) (51)
- Blood hypomethylation of inflammatory genes mediates the effects of metal-rich airborne pollutants on blood coagulation (2013) (51)
- Lupus anticoagulant detection in anticoagulated patients. Guidance from the Scientific and Standardization Committee for lupus anticoagulant/antiphospholipid antibodies of the International Society on Thrombosis and Haemostasis (2020) (50)
- Asymptomatic homozygous protein C deficiency. (1990) (50)
- The Italian START-Register on Anticoagulation with Focus on Atrial Fibrillation (2015) (49)
- Residual venous obstruction, alone and in combination with D-dimer, as a risk factor for recurrence after anticoagulation withdrawal following a first idiopathic deep vein thrombosis in the prolong study. (2010) (49)
- Factor VII Clotting Assay: Influence of Different Thromboplastins and Factor VII-Deficient Plasmas (1991) (48)
- D-dimer testing for suspected venous thromboembolism in the emergency department. Consensus document of AcEMC, CISMEL, SIBioC, and SIMeL (2014) (46)
- Fibrinogen measurement in cardiac surgery with cardiopulmonary bypass: Analysis of repeatability and agreement of Clauss method within and between six different laboratories (2014) (46)
- To measure or not to measure direct oral anticoagulants before surgery or invasive procedures (2016) (46)
- Determination of the International Sensitivity Index of a New Near-Patient Testing Device to Monitor Oral Anticoagulant Therapy (1997) (45)
- The concept of rebalanced hemostasis in patients with liver disease: Communication from the ISTH SSC working group on hemostatic management of patients with liver disease (2021) (43)
- Assessment of the risk of bleeding in patients undergoing surgery or invasive procedures: Guidelines of the Italian Society for Haemostasis and Thrombosis (SISET). (2009) (43)
- Assessment of the Influence of Citrate Concentration on the International Normalized Ratio (INR) Determined with Twelve Reagent-instrument Combinations (1998) (43)
- Determination of total homocysteine in plasma: comparison of the Abbott IMx immunoassay with high performance liquid chromatography. (2002) (43)
- Effects of Hirudin on Activated Partial Thromboplastin Time Determined with Ten Different Reagents (1993) (42)
- Lupus anticoagulants and their relationship with the inhibitors against coagulation factor VIII: considerations on the differentiation between the 2 circulating anticoagulants. (2005) (42)
- Markers of activated coagulation and their usefulness in the clinical laboratory. (1996) (42)
- A multicentre randomised clinical endpoint study of parma 5 computer‐assisted oral anticoagulant dosage (2008) (41)
- Comparison of Functional Assays for Protein S: European Collaborative Study of Patients with Congenital and Acquired Deficiency (1993) (41)
- Testing for lupus anticoagulants: all that a clinician should know (2009) (41)
- A review of the clinical and diagnostic utility of laboratory tests for the detection of congenital thrombophilia. (2005) (39)
- The international normalized ratio to prioritize patients for liver transplantation: problems and possible solutions. (2008) (39)
- Measurement of warfarin in plasma by high performance liquid chromatography (HPLC) and its correlation with the international normalized ratio. (2003) (39)
- Use of D-dimer testing to determine duration of anticoagulation, risk of cardiovascular events and occult cancer after a first episode of idiopathic venous thromboembolism: the extended follow-up of the PROLONG study (2009) (38)
- Quality assessment of CoaguChek point-of-care prothrombin time monitors: comparison of the European community-approved procedure and conventional external quality assessment. (2006) (38)
- Multicentric Evaluation of a New PT Reagent Based on Recombinant Human Tissue Factor and Synthetic Phospholipids (1994) (38)
- Liver Disease and Hemostatic (Dys)function (2015) (37)
- Liver disease, coagulopathies and transfusion therapy. (2013) (37)
- Multicenter Comparison of Five Functional and Two Immunological Assays for Protein C (1987) (37)
- A national field study of quality assessment of CoaguChek point-of-care testing prothrombin time monitors. (2006) (37)
- How the direct oral anticoagulant apixaban affects thrombin generation parameters. (2015) (37)
- Different cut-off values of quantitative D-dimer methods to predict the risk of venous thromboembolism recurrence: a post-hoc analysis of the PROLONG study (2008) (37)
- European Concerted Action on Anticoagulation (ECAA): multicentre international sensitivity index calibration of two types of point‐of‐care prothrombin time monitor systems (2002) (37)
- Extracellular vesicle-driven information mediates the long-term effects of particulate matter exposure on coagulation and inflammation pathways. (2016) (36)
- Minimum lyophilized plasma requirement for ISI calibration. European Concerted Action on Anticoagulation. (1998) (36)
- Relatively Poor Performance of Clinical Laboratories for DNA Analyses in the Detection of Two Thrombophilic Mutations – A Cause for Concern (2002) (35)
- Anticoagulant Treatment With Rivaroxaban in Severe Protein S Deficiency (2013) (35)
- To Mix or Not to Mix in Lupus Anticoagulant Testing? That is the Question (2012) (35)
- Sex, age and normal post‐anticoagulation D‐dimer as risk factors for recurrence after idiopathic venous thromboembolism in the Prolong study extension (2010) (35)
- Prothrombin Fragment 1+2 and Intensity of Treatment with Oral Anticoagulants (1991) (35)
- Emergency management in patients with haemophilia A and inhibitors on prophylaxis with emicizumab: AICE practical guidance in collaboration with SIBioC, SIMEU, SIMEUP, SIPMeL and SISET. (2020) (34)
- Laboratory monitoring of anticoagulation: where do we stand? (2009) (34)
- The risk of a first and a recurrent venous thrombosis associated with an elevated D‐dimer level and an elevated thrombin potential: results of the THE‐VTE study: comment (2015) (33)
- Vitamin K antagonist therapy: changes in the treated populations and in management results in Italian anticoagulation clinics compared with those recorded 20 years ago (2017) (33)
- Reporting prothrombin time results as international normalized ratios for patients with chronic liver disease (2010) (33)
- Recombinant Tissue Factor as Substitute for Conventional Thromboplastin in the Prothrombin Time Test (1992) (33)
- Homozygous protein C deficiency with moderately severe clinical symptoms. (1986) (33)
- The cost‐effectiveness of computer‐assisted anticoagulant dosage: results from the European Action on Anticoagulation (EAA) multicentre study (2009) (33)
- Recurrent thrombosis in patients with antiphospholipid antibodies treated with vitamin K antagonists or rivaroxaban (2018) (32)
- A partial factor V deficiency in anticoagulated lyophilized plasmas has been identified as a cause of the international normalized ratio discrepancy in the external quality assessment scheme. (1995) (32)
- The coagulopathy of chronic liver disease: is there a causal relationship with bleeding? No. (2010) (32)
- New anticoagulant drugs for treatment of venous thromboembolism and stroke prevention in atrial fibrillation (2012) (32)
- Management of cerebral and splanchnic vein thrombosis associated with thrombocytopenia in subjects previously vaccinated with Vaxzevria (AstraZeneca): a position statement from the Italian Society for the Study of Haemostasis and Thrombosis (SISET). (2021) (31)
- Position paper on laboratory testing for patients taking new oral anticoagulants. Consensus document of FCSA, SIMeL, SIBioC and CISMEL1) (2012) (31)
- A Comparison of Two Sodium Citrate Concentrations in Two Evacuated Blood Collection Systems for Prothrombin Time and ISI Determination (2000) (31)
- Prevalence and significance of anti-prothrombin (aPT) antibodies in patients with Lupus Anticoagulant (LA). (2010) (30)
- Phase III studies on novel oral anticoagulants for stroke prevention in atrial fibrillation: a look beyond the excellent results (2012) (30)
- Hemostatic alterations in COVID-19 (2020) (30)
- Antithrombin Milano, Single Amino Acid Substitution at the Reactive Site, Arg393 to Cys (1988) (30)
- Levels of coagulation factors and venous thromboembolism. (2003) (30)
- Detection of procoagulant imbalance (2017) (30)
- Influence of Three Types of Automated Coagulometers on the International Sensitivity Index (ISI) of Rabbit, Human, and Recombinant Human Tissue Factor Preparations (1999) (29)
- Global coagulation in myeloproliferative neoplasms (2013) (29)
- Age and gender specific cut-off values to improve the performance of d-dimer assays to predict the risk of venous thromboembolism recurrence (2013) (29)
- D-Dimer Testing in Laboratory Practice* (2012) (29)
- EVALUATION OF A FULLY AUTOMATED CENTRIFUGAL ANALYSER FOR ITS PERFORMANCE OF HEMOSTASIS TESTS (1987) (28)
- A Proposed Scheme for Calibration of International Reference Preparations of Thromboplastin for the Prothrombin Time (1995) (28)
- A new chromogenic assay (HemosIL ThromboPath) is sensitive to major prothrombotic risk factors affecting the protein C pathway. Results of a multicenter study. (2007) (28)
- Laboratory testing for lupus anticoagulants: diagnostic criteria and use of screening, mixing, and confirmatory studies. (2008) (28)
- Hyperprothrombinemia may result in acquired activated protein C resistance (2000) (28)
- Antithrombin Milano: a new variant with monomeric and dimeric inactive antithrombin III. (1985) (28)
- Hemostasis in Acute and Chronic Liver Disease (2017) (28)
- How and when to measure anticoagulant effects of direct oral anticoagulants? Practical issues. (2018) (27)
- Rescue factor VIII replacement to secure hemostasis in a patient with hemophilia A and inhibitors on emicizumab prophylaxis undergoing hip replacement (2019) (27)
- External quality assessment (EQA) for CoaguChek monitors (2010) (27)
- European Concerted Action on Anticoagulation (ECAA) - The Multicentre Calibration of Rabbit and Human ECAA Reference Thromboplastins (1996) (27)
- The European Concerted Action on Anticoagulation (ECAA): Field Studies of Coagulometer Effects on the ISI of ECAA Thromboplastins (1998) (27)
- Factor VIII clotting activity (1999) (26)
- Variability of cut‐off values for the detection of lupus anticoagulants: results of an international multicenter multiplatform study (2017) (26)
- European concerted action on anticoagulation. Use of plasma samples to derive international sensitivity index for whole-blood prothrombin time monitors. (2002) (26)
- The Effect of Instrumentation on Thromboplastin Calibration (1992) (26)
- The recommended dose of idarucizumab may not always be sufficient for sustained reversal of dabigatran: comment (2017) (25)
- International collaborative study for the calibration of a proposed international standard for thromboplastin, rabbit, plain (2006) (25)
- Comparison of local International Sensitivity Index calibration and ‘Direct INR’ methods in correction of locally reported International Normalized Ratios: an international study (2007) (25)
- Point-of-care coagulation monitors calibrated for the international normalized ratio for cirrhosis (INRliver) can help to implement the INRliver for the calculation of the MELD score. (2009) (25)
- Calibration of Local Systems with Lyophilized Calibrant Plasmas Improves the Interlaboratory Variability of the INR in the Italian External Quality Assessment Scheme (1999) (25)
- Laboratory screening of thrombophilia. Evaluation of the diagnostic efficacy of a global test to detect congenital deficiencies of the protein C anticoagulant pathway (1998) (25)
- Coagulation parameters in patients with cirrhosis and portal vein thrombosis treated sequentially with low molecular weight heparin and vitamin K antagonists. (2016) (24)
- Changes of Prothrombin Fragment 1+2 (F 1+2) as a Function of Increasing Intensity of Oral Anticoagulation (1998) (24)
- Hypercoagulability in patients with Cushing disease detected by thrombin generation assay is associated with increased levels of neutrophil extracellular trap-related factors (2017) (24)
- More on: laboratory investigation of lupus anticoagulants: mixing studies are sometimes required (2011) (24)
- European concerted action on anticoagulation. Quality assessment of the CoaguChek Mini and TAS PT-NC point-of-care whole-blood prothrombin time monitors. (2004) (24)
- Standardization of the endogenous thrombin potential measurement: how to minimize the effect of residual platelets in stored plasma (2004) (24)
- Abnormal Protac-induced coagulation inhibition chromogenic assay results are associated with an increased risk of recurrent venous thromboembolism (2010) (23)
- Results of a Multicenter Study Assessing the Status of Standardization of a Recombinant Thromboplastin for the Control of Oral Anticoagulant Therapy (1994) (23)
- Monitoring patients with the lupus anticoagulant while treated with vitamin K antagonists: communication from the SSC of the ISTH (2016) (23)
- A Reassessment of the Relationship between International Reference Preparations for Human and Rabbit Thromboplastins (2002) (23)
- How to evaluate the influence of blood collection systems on the international sensitivity index. Protocol applied to two new evacuated tubes and eight coagulometer/thromboplastin combinations. (2002) (22)
- European Concerted Action on Anticoagulation (ECAA). An assessment of lyophilised plasmas for ISI calibration of CoaguChek and TAS whole blood prothrombin time monitors (2003) (22)
- Guidelines for thromboplastins and plasma used to control oral anticoagulant therapy with vitamin K antagonists (2013) (22)
- The vexed question of whether or not to measure levels of direct oral anticoagulants before surgery or invasive procedures (2018) (22)
- Activated partial thromboplastin time (APTT). New indications for an old test? (2006) (21)
- Evaluation of coagulation during treatment with directly acting antivirals in patients with hepatitis C virus related cirrhosis (2017) (21)
- Poor Comparability of Prothrombin Fragment 1 + 2 Values Measured by Two Commercial ELISA Methods: Influence of Different Anticoagulants and Standards (1994) (21)
- Measuring the anticoagulant effect of direct factor Xa inhibitors. Is the anti-Xa assay preferable to the prothrombin time test? (2011) (21)
- Advances in the Treatment of Hemophilia: Implications for Laboratory Testing. (2019) (21)
- How to report results of prothrombin and activated partial thromboplastin times (2016) (21)
- A survey of inherited thrombotic syndromes in italy (1989) (21)
- Recommendations for the measurement of thrombin generation: Communication from the ISTH SSC Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibodies (2021) (20)
- Interlaboratory variability in the measurement of direct oral anticoagulants: results from the external quality assessment scheme (2018) (20)
- Mechanisms, markers and management of hypercoagulable states. (1996) (20)
- Results of a collaborative study for fibrinogen measurement. Evidence that the use of a common calibrator improves interlaboratory agreement (1994) (20)
- Residual platelets are the main determinants of microparticles count in frozen-thawed plasma. (2012) (20)
- Antithrombin III Milano 2: a single base substitution in the thrombin binding domain detected with PCR and direct genomic sequencing. (1989) (20)
- More on: high thrombin generation and the risk of recurrent venous thromboembolism (2009) (19)
- A guide to oral anticoagulant therapy (1998) (19)
- Multicenter Evaluation of Three Commercial Methods for Measuring Protein S Antigen (1992) (19)
- Markers of procoagulant imbalance in patients with localized melanomas and autoimmune disorders (1993) (18)
- European Concerted Action on Anticoagulation. A multicentre calibration study of WHO international reference preparations for thromboplastin, rabbit (RBT/90) and human (rTF/95) (2005) (18)
- Inherited factors in thrombosis. (1988) (18)
- Which test to use to measure the anticoagulant effect of rivaroxaban: the prothrombin time test (2013) (18)
- To measure or not to measure direct oral anticoagulants before surgery or invasive procedures: reply (2016) (18)
- Laboratory diagnostic outcome applying detection criteria recommended by the Scientific and Standardization Committee of the ISTH on Lupus Anticoagulant (2013) (18)
- Hemostasis abnormalities in liver cirrhosis: myth or reality? (2008) (18)
- A Simplified Procedure for Thromboplastin Calibration -The Usefulness of Lyophilized Plasmas Assessed in a Collaborative Study (1996) (18)
- Laboratory tests during direct oral anticoagulant treatment (2013) (18)
- Hemostasis in chronic liver disease (2006) (18)
- Functional Assays of Protein C: Comparison of Two Snake-Venom Assays with Two Thrombin Assays (1988) (17)
- Performance of clinical laboratories for DNA analyses to detect thrombophilia mutations. (2005) (17)
- Oral anticoagulant monitoring by laboratory or near-patient testing: what a clinician should be aware of. (2003) (17)
- Under the auspices of the Italian Association for the Study of Liver Diseases (AISF) and the Italian Society of Internal Medicine (SIMI) (2016) (17)
- International Collaborative Study for the Calibration of a Proposed International Standard for thromboplastin, human, plain (2006) (17)
- Quality assurance program for whole blood prothrombin time-international normalized ratio point-of-care monitors used for patient self-testing to control oral anticoagulation. (2004) (17)
- Comorbidities, alone and in combination with D-dimer, as risk factors for recurrence after a first episode of unprovoked venous thromboembolism in the extended follow-up of the PROLONG study (2010) (16)
- How to implement the modified international normalized ratio for cirrhosis (INRliver) for model for end‐stage liver disease calculation (2008) (16)
- Thromboelastographic profiles of healthy very low birthweight infants serially during their first month (2019) (16)
- Multicenter evaluation of a new chromogenic factor X assay in plasma of patients on oral anticoagulants. (1980) (16)
- A guide to oral anticoagulant treatment. Recommendations of the Italian federation of anticoagulation clinics (FCSA) (2003) (16)
- Critical laboratory values in hemostasis: toward consensus (2017) (15)
- Performance of quantitative D‐dimer methods: results of the Italian external quality assessment scheme (2007) (15)
- Effect of daptomycin on prothrombin time and the requirement for outlier exclusion in International Sensitivity Index calibration of thromboplastin (2007) (15)
- European Concerted Action on Anticoagulation. Evaluation of a method for International Sensitivity Index calibration of two point-of-care prothrombin time (PT) monitoring systems (CoaguChek Mini and TAS PT-NC) with fresh plasmas based on whole-blood equivalent PT. (2002) (15)
- The importance of "like to like" ISI calibrations with freeze dried plasmas. European Concerted Action on Anticoagulation. (1998) (15)
- The history of phenotypic testing in thrombosis and hemostasis. (2008) (15)
- Statins decrease thrombin generation in patients with hypercholesterolemia. (2014) (15)
- International collaborative study for the calibration of proposed International Standards for thromboplastin, rabbit, plain, and for thromboplastin, recombinant, human, plain (2018) (15)
- Standardization of the APC Resistance Test. Effects of Normalization of Results by Means of Pooled Normal Plasma (1998) (15)
- Multicenter Evaluation of Lyophilized and Deep-frozen Plasmas for Assignment of the International Normalized Ratio (1999) (15)
- How the direct oral anticoagulant apixaban affects hemostatic parameters. Results of a multicenter multiplatform study (2015) (15)
- Factor VIII activity as measured by an amidolytic assay compared with a one-stage clotting assay. (1986) (15)
- Familial Overexpression of β Antithrombin Caused by an Asn135Thr Substitution (1999) (14)
- Management of patients with severe haemophilia a without inhibitors on prophylaxis with emicizumab: AICE recommendations with focus on emergency in collaboration with SIBioC, SIMEU, SIMEUP, SIPMeL and SISET (2020) (14)
- Clinical evaluation of a fully automated chromogenic method for prothrombin time compared with a conventional coagulation method. (1984) (14)
- A guide to oral anticoagulant treatment (1998) (14)
- Laboratory Diagnosis of Lupus Anticoagulants (2002) (14)
- The European Concerted Action on Anticoagulation (ECAA) Evaluation of a Set of Lyophilized Normal Plasmas to Establish the Normal Prothrombin Time for Coagulometer Systems (1998) (14)
- The long-awaited whole-blood thrombin generation test. (2012) (14)
- Prothrombin time international normalized ratio monitoring by self-testing (2004) (14)
- The effect of sample size on fresh plasma thromboplastin ISI determination (1999) (14)
- European Concerted Action on Anticoagulation (ECAA): International Normalized Ratio Variability of CoaguChek and TAS Point-of-Care Testing Whole Blood Prothrombin Time Monitors (2002) (14)
- Familial Overexpression of β Antithrombin Caused by an Asn135Thr Substitution (1999) (14)
- Periprocedural management of abnormal coagulation parameters and thrombocytopenia in patients with cirrhosis: Guidance from the SSC of the ISTH (2022) (14)
- Interactions of adenoviruses with platelets and coagulation and the vaccine-induced immune thrombotic thrombocytopenia syndrome (2021) (14)
- Biological variation of INR in stable patients on long-term anticoagulation with warfarin. (2012) (13)
- Familial dysfunctional protein C. (1986) (13)
- Comparison of thrombin generation for paired‐platelet‐rich plasma collected with and without corn trypsin inhibitor from hemophiliacs treated with factor‐VIII inhibitor bypassing agents (2012) (13)
- Nontransfusional approach to increased platelet count in patients with cirrhosis and thrombocytopenia (2013) (13)
- Definition of the International Normalized Ratio (INR) and its consequences for the calibration procedure of thromboplastin preparations: a rebuttal (2004) (13)
- Thrombin generation and other coagulation parameters in a patient with homozygous congenital protein S deficiency on treatment with rivaroxaban (2016) (12)
- European Concerted Action on Anticoagulation. Correction of displayed international normalized ratio on two point‐of‐care test whole‐blood prothrombin time monitors (CoaguChek Mini and TAS PT‐NC) by independent international sensitivity index calibration (2003) (12)
- Position paper on laboratory testing for patients with haemophilia. A consensus document from SISET, AICE, SIBioC and SIPMeL. (2019) (12)
- Laboratory tests and the new oral anticoagulants. (2012) (12)
- Mechanisms of Disease The Coagulopathy of Chronic Liver Disease (2011) (12)
- Problems and Solutions for Testing Hemostasis Assays while Patients Are on Anticoagulants (2012) (12)
- European Concerted Action on Anticoagulation (ECAA): an assessment of a method for ISI calibration of two whole blood point‐of‐care PT monitor systems based on lyophilized plasmas using whole blood equivalent PT (2003) (12)
- Extracellular histones mediate the effects of metal-rich air particles on blood coagulation. (2014) (12)
- Managing oral anticoagulant therapy: an Italian Perspective (2003) (11)
- Correction for Lack of Coincidence of Normal and Abnormal Calibration Slopes in ISI Determination (1999) (11)
- Comparison of five specific assays for determination of dabigatran plasma concentrations in patients enrolled in the START‐Laboratory Register (2018) (11)
- “Periprocedural management of abnormal coagulation parameters and thrombocytopenia in patients with cirrhosis: Guidance from the SSC of the ISTH”: Reply (2021) (11)
- Comparison of a functional assay for protein C with two immunoassays. (1985) (11)
- More on: criteria to define the antiphospholipid syndrome (2008) (11)
- The intra-assay reproducibility of thromboelastography in very low birth weight infants. (2018) (10)
- Emicizumab, the factor VIII mimetic bi-specific monoclonal antibody and its measurement in plasma (2020) (10)
- Haemostasis Abnormalities in Chronic Liver Failure (2011) (10)
- Minimum numbers of fresh whole blood and plasma samples from patients and healthy subjects for ISI calibration of CoaguChek and RapidPointCoag monitors. (2002) (10)
- International sensitivity index calibration of the near-patient testing prothrombin time monitor, ProTime. (2003) (10)
- Heparin induced thrombocytopenia: position paper from the Italian Society on Thrombosis and Haemostasis (SISET). (2020) (10)
- Thromboplastin standards. (2010) (10)
- Body mass index reduction improves the baseline procoagulant imbalance of obese subjects (2019) (9)
- Results expression for tests used to measure the anticoagulant effect of new oral anticoagulants (2013) (9)
- Effect of Oral Aspirin on Plasma Levels of Vitamin K-Dependent Clotting Factors – Studies in Healthy Volunteers (1988) (9)
- Unexpected, isolated activated partial thromboplastin time prolongation: A practical mini‐review (2020) (9)
- Assessment of Platelet Thrombus Formation under Flow Conditions in Adult Patients with COVID-19: An Observational Study (2021) (9)
- Issues Concerning the Laboratory Investigation of Inherited Thrombophilia (2012) (9)
- Effects of subcutaneously administered dermatan sulfate (MF 701) on the coagulation and fibrinolytic parameters of healthy volunteers. (1991) (9)
- Low thrombin generation during major orthopaedic surgery fails to predict the bleeding risk in inhibitor patients treated with bypassing agents (2016) (9)
- The influence of factor V Leiden and G20210A prothrombin mutation on the presence of residual vein obstruction after idiopathic deep-vein thrombosis of the lower limbs (2013) (9)
- Evaluation of a new PT‐INR monitoring system in patients with the antiphospholipid syndrome (2016) (9)
- Acquired haemophilia A: Italian Consensus Recommendations on diagnosis, general management and treatment of bleeding. (2022) (9)
- Standardization of activated protein C resistance testing: effect of residual platelets in frozen plasmas assessed by commercial and home‐made methods (2003) (9)
- Questions and answers on the use of dabigatran and perpectives on the use of other new oral anticoagulants in patients with atrial fibrillation. (2011) (9)
- Procoagulant imbalance in preterm neonates detected by thrombin generation procedures. (2019) (8)
- Laboratory diagnosis of thrombophilic states: where do we stand? (2002) (8)
- A simplified statistical method for local INR using linear regression (1997) (8)
- The thrombin generation assay distinguishes inhibitor from non‐inhibitor patients with severe haemophilia A (2016) (8)
- Lupus Anticoagulant Testing: Activated Partial Thromboplastin Time (APTT) and Silica Clotting Time (SCT). (2017) (8)
- Standardization of lupus anticoagulant. Feasibility study of a calibration model to minimize between-method variability. (2011) (8)
- Congenital deficiencies of anticoagulant proteins (antithrombin III and protein C). (1984) (8)
- Treatment with stanazolol of type I protein C deficiency in an Italian family (1984) (8)
- Multicentre comparison of nine coagulometers and manual tilt-tube methods for prothrombin time performance. (1983) (8)
- Procoagulant imbalance influences cardiovascular and liver damage in chronic hepatitis C independently of steatosis (2019) (8)
- European concerted action on anticoagulation. Minimum numbers of lyophilized plasma samples for ISI calibration of CoaguChek and TAS point-of-care whole blood prothrombin time monitors. (2003) (8)
- Pro-coagulant imbalance in patients with chronic liver disease. (2010) (8)
- Paving the way for establishing a reference measurement system for standardization of plasma prothrombin time: Harmonizing the manual tilt tube method (2020) (7)
- Anticoagulant Treatment With Rivaroxaban in Severe Protein (2013) (7)
- Alpha(2)-macroglobulin levels are high in adult patients with congenital antithrombin deficiency. (2000) (7)
- LETTERS TO THE EDITOR: Is there a need for replacement of the International Reference Preparation for Thromboplastin, Bovine, Combined (OBT/79)? (2005) (7)
- False‐negative or false‐positive: laboratory diagnosis of lupus anticoagulant at the time of commencement of anticoagulant: a rebuttal (2011) (7)
- Thrombin activatable fibrinolysis inhibitor pathway alterations correlate with bleeding phenotype in patients with severe hemophilia A (2020) (7)
- Inherited deficiency of antithrombin III in an Italian kindred (1980) (7)
- Massive cerebral venous thrombosis due to vaccine-induced immune thrombotic thrombocytopenia (2021) (7)
- Characterization of an Abnormal Antithrombin (Milano 2) with Defective Thrombin Binding (1986) (7)
- Thrombin generation: a global coagulation procedure to investigate hypo- and hyper-coagulability (2020) (7)
- Monitoring Oral Anticoagulant Therapy (2009) (7)
- Screening computer‐assisted dosage programs for anticoagulation with warfarin and other vitamin K antagonists: minimum safety requirements for individual programs (2009) (7)
- Risk of Venous Thromboembolism and Clinical Manifestations in Carriers of Antithrombin , Protein C , Protein S Deficiency , or Activated Protein C Resistance (1999) (7)
- Usefulness of Thrombin Generation (2020) (7)
- D-dimer testing, with gender-specific cutoff levels, is of value to assess the individual risk of venous thromboembolic recurrence in non-elderly patients of both genders: a post hoc analysis of the DULCIS study (2019) (7)
- Thrombin generation in patients with idiopathic sudden sensorineural hearing loss. (2014) (7)
- Familial overexpression of beta antithrombin caused by an Asn135Thr substitution. (1999) (7)
- Assessment of a new instrument (Coag-A-Mate X2) for performing global clotting tests and specific factor assays. (1985) (6)
- European Concerted Action on Anticoagulation (ECAA). Minimum number of centres for reliable International Sensitivity Index calibration of CoaguChek and TAS point-of-care whole blood monitors. (2002) (6)
- Elevation of thrombin-antithrombin complexes during thrombolytic therapy in patients with myocardial infarction (1990) (6)
- Hypercoagulability in Patients with Non-Alcoholic Fatty Liver Disease (NAFLD): Causes and Consequences (2022) (6)
- Procoagulant Imbalance in Klinefelter Syndrome Assessed by Thrombin Generation Assay and Whole-Blood Thromboelastometry (2020) (6)
- Hyperprothrombinemia may result in scquired activated protein C reistance. (2000) (6)
- Impact of a commercially available DOAC absorbent on two integrated procedures for lupus anticoagulant detection. (2021) (6)
- Discrepancy of the international normalized ratio observed in the external quality assessment survey: a cause for concern (2012) (6)
- Interference of new oral anticoagulants with frequently used coagulation tests (2012) (6)
- More on: enhanced thrombin generation in patients with cirrhosis‐induced coagulopathy (2011) (6)
- Is placental blood a reliable source for the evaluation of neonatal hemostasis at birth? (2020) (6)
- Periprocedural management of rivaroxaban-treated patients (2015) (5)
- The international normalized ratio to prioritize patients for liver transplantation: problems and possible solutions (2008) (5)
- Failure of corn trypsin inhibitor to affect the thrombin generation assay in plasma from severe haemophiliacs: comment (2015) (5)
- Self-testing and self-monitoring of oral anticoagulant therapy: consensus of the Italian Federation of Anticoagulation Clinics (2003) (5)
- The validity of the INR system for patients with liver disease (2011) (5)
- A(nother) test meant to fill the gap between in vivo and ex vivo hemostasis. (2014) (5)
- Long-term stability of relationships between reference materials for thromboplastins (2006) (5)
- No changes of parameters nor coagulation activation in healthy subjects vaccinated for SARS-Cov-2 (2021) (5)
- Hyperprothrombinaemia-induced APC resistance: Differential influence on fibrin formation and fibrinolysis (2006) (5)
- Direct oral anticoagulants and cirrhosis: More evidence still needed for efficacy and safety in portal vein thrombosis. (2019) (5)
- Anti-TNF-α Treatment Reduces the Baseline Procoagulant Imbalance of Patients With Inflammatory Bowel Diseases. (2021) (5)
- An in vitro study to investigate the interference of enoxaparin on plasma levels of direct oral factor Xa inhibitors measured by chromogenic assays (2019) (5)
- Control of Oral Anticoagulant Therapy with Whole Blood Prothrombin Time Devices: the Future Has Begun (2000) (4)
- Interference of factor V Leiden on protein S activity: evaluation of a new prothrombin time-based assay (2007) (4)
- Comments on: Laboratory tests for the management of major bleeding complications and emergency surgery in patients on long-term treatment with direct oral anticoagulants: proposals of the Working Group on Perioperative Haemostasis (GIHP). (2014) (4)
- Usefulness of lyophilized calibration plasmas for International Normalized Ratio determination with the bovine combined thromboplastin (Thrombotest): results of a collaborative study (2005) (4)
- Effect of different methods for outlier detection and rejection when calculating cut off values for diagnosis of lupus anticoagulants. (2020) (4)
- Ischemic stroke in congenital (type II C) defective antithrombin III (1993) (4)
- Quality assessment of coaguchek monitors: comparative analysis of the ECAA and conventional external QA (2007) (4)
- To measure or not to measure direct oral anticoagulants before surgery or invasive procedures: reply (2017) (4)
- An assessment of a method for ISI calibration of two whole blood point-of-care PT monitor systems based on lyophilised plasmas using whole blood equivalent PT (2003) (4)
- Requirement of a reference measurement system for the tissue factor-induced coagulation time and the international normalized ratio (2018) (4)
- Thromboelastometry. Reproducibility of duplicate measurement performed by the RoTem® device. (2018) (4)
- Diagnostic Challenges on the Laboratory Detection of Lupus Anticoagulant (2021) (4)
- Is Hemophilia B Less Severe Than Hemophilia A? Results Of Global Coagulation Assays (2013) (4)
- Thrombin generation assay for testing hemostatic effect of factor VIII concentrates in patients with hemophilia A and inhibitors: In vitro results from the PredicTGA study. (2019) (4)
- Additional laboratory tests to improve on the diagnosis of antiphospholipid syndrome (2020) (3)
- Purification and Further Characterization of Antithrombin III Milano: Lack of Reactivity with Thrombin (1987) (3)
- The D-dimer (DD) test to establish the duration of anticoagulation after a first unprovoked episod of venous thromboembolism (VTE); the prospective randomized “Prolong” Study on behalf of the Italian Federation of Anticoagulation Clinics (FCSA) (2005) (3)
- Thromboprophylaxis for venous thromboembolism prevention in hospitalized patients with cirrhosis: Guidance from the SSC of the ISTH (2022) (3)
- Coagulation and fibrosis: A potential non-negligible target of statins in chronic hepatitis. (2015) (3)
- Increased Thrombin Generation in Severe Hemophiliacs with Mild Clinical Phenotype (2008) (3)
- Evaluation of an Enzymatic Method to Measure Total Homocysteine in Plasma (2002) (3)
- Simvastatin Prevents Liver Microthrombosis and Sepsis Induced Coagulopathy in a Rat Model of Endotoxemia (2022) (3)
- Relationship between thrombin generation parameters and prothrombin fragment 1 + 2 plasma levels (2021) (2)
- Implementing pre-procedural thrombopoietin receptor agonists in cirrhotic patients with severe thrombocytopenia: Indiscriminate, selective or unneeded? (2021) (2)
- Interplay between coagulation and determinants of liver disease in patients with metabolic dysfunction (2022) (2)
- Letter to the Editor: Thromboelastography‐Guided Blood Product Transfusion in Cirrhosis With Coagulopathy: Real Saving or Just Less Waste? (2020) (2)
- Effect of prothrombin time outlier exclusion rules on ISI calibration in multicentre studies. (2010) (2)
- Thrombin Generation in Preterm Newborns With Intestinal Failure-Associated Liver Disease (2020) (2)
- Rebuttal to letter "Is thromboprophylaxis with high-dose enoxaparin really necessary for COVID-19 patients? A new "prudent" randomised clinical trial". (2020) (2)
- Automated amidolytic method for evaluating the activated partial thromboplastin time compared with a conventional coagulation method. (1989) (2)
- Increased Thrombin Generation in Inflammatory Bowel Diseases (2008) (2)
- Minimum numbers of ECAA lyophilized plasmas for ISI calibration of CoaguChek and TAS point-of-care whole blood prothrombin time monitors (2003) (2)
- Reply to: Endogenous heparinoids contribute to coagulopathy in patients with liver disease (2008) (2)
- An improved method for measuring red blood cell filterability (1985) (2)
- Monitoring Oral Anticoagulant Therapy with Vitamin K Antagonists (2013) (2)
- Whole blood platelet aggregation measurement by Multiplate™: potential diagnostic inaccuracy of correcting the results for the sample platelet count. (2022) (1)
- A chromogenic assay of prothrombin compared with coagulation tests during anticoagulant therapy and liver disease (1981) (1)
- Activated partial thromboplastin time: results of a case–control study evaluating six commercial reagents in assessing the risk of venous thromboembolism (2006) (1)
- Fibrinogen and factor VII as risk factors for ischemic heart disease (1995) (1)
- A national field study of quality assessment (qa) og coaguchek monitors (2007) (1)
- Rational hemostatic management in cirrhosis: from old paradigms to new clinical challenges (2022) (1)
- Monitoring Warfarin Therapy in Patients with Lupus Anticoagulants (LA) (1998) (1)
- Hemostasis from Bench to Bedside: The History of Three Successful Stories of Translational Medicine (2022) (1)
- Standardization of lupus anticoagulant. The Lupus Anticoagulant Sensitivity Index (LASI) (2012) (1)
- Evaluation of procoagulant imbalance in Cushing’s syndrome after short- and long-term remission of disease (2021) (1)
- Warfarin prescription in patients with nonvalvular atrial fibrillation and one non–gender‐related risk factor (CHA2DS2VASc 1 or 2): A treatment dilemma (2018) (1)
- The accuracy of the International Normalized Ratio and the American College of Chest Physicians recommendations on the use of vitamin K to reverse over‐anticoagulation (2012) (1)
- Pro-coagulant imbalance in patients with community acquired pneumonia assessed on admission and one month after hospital discharge (2021) (1)
- Position paper on the safety/efficacy profile of direct oral anticoagulants in patients with chronic kidney disease. Consensus document from the SIN, FCSA and SISET. (2020) (1)
- Residual venous obstruction and D-dimer as risk factors for recurrence after anticoagulation withdrawal for a first idiopathic deep vein thrombosis in the prolong study (2008) (1)
- More on: Properties of recombinant human thromboplastins that determine the International Sensitivity Index (ISI) (2005) (1)
- Successful Calibration of a Reagent from Human Placenta against rTF/95, the WHO International Reference Preparation for Thromboplastin, Human Recombinant, Plain (1998) (1)
- A comparison of linear and orthogonal regression analysis for local INR determination in ECAA coagulometer studies. European Concerted Action on Anticoagulation. (1998) (1)
- Effect of emicizumab on global coagulation assays for plasma supplemented with apixaban or argatroban (2019) (1)
- [The role of erythrocyte deformability in the prolonged bleeding time in liver disease patients]. (1985) (1)
- THE PAST AS PROLOGUE — CIRRHOSIS AS THE EPITOME OF THE HEMORRHAGIC DISEASES ? (2016) (1)
- More on: new antithrombotics: a need for laboratory monitoring. For or against (2010) (1)
- Calibration of combined thromboplastins with the International Standard for Thromboplastin, rabbit, plain (2011) (1)
- Fresh frozen plasma transfusion fails to influence the hemostatic balance in critically ill patients with a coagulopathy: comment (2015) (1)
- Management of special conditions in patients on vitamin K antagonists (2012) (1)
- Thrombin Generation in Severe Hemophiliacs with Different Clinical Phenotype. (2006) (1)
- Commentary (1990) (0)
- Anticoagulanti naturali come cause di trombosi eredofamiliari. (1990) (0)
- Hemosil ThromboPath : a chromogenic assay sensitive to major prothrombotic risk factors affecting the protein C pathway (2005) (0)
- Authors Index, Vol. 26, Supplement 4, 1996 (1996) (0)
- inhibits plasma fibrinolysis through a TAFI-mediated mechanism Hyperprothrombinemia associated with prothrombin G20210A mutation (2013) (0)
- Contents Vol. 32, 2002 (2002) (0)
- Responsiveness of the activated partial thromboplastin time and dilute thrombin time to argatroban: Results of an in vitro study (2020) (0)
- Minimum numbers of centres for reliable ISI calibration of CoaguChek and TAS point-of-care whole blood monitors (2002) (0)
- Evaluation of a Method for International Sensitivity Index Calibration of Two Point-of-Care Prothrombin Time (PT) Monitoring Systems with Fresh Plasmas Based on Whole-Blood Equivalent PT (2002) (0)
- Clinical and genetic determinants of the fatty liver–coagulation balance interplay in individuals with metabolic dysfunction (2022) (0)
- The role of anticoagulation clinics needs to be reassessed to include follow up of patients on direct oral anticoagulants. (2023) (0)
- Activated protein C (APC) resistance (1999) (0)
- A multicentre randomised clinical end-point study of PARMA 5 computer-assisted oral anticoagulant dosage: On behalf of the European Action on Anticoagulation (2008) (0)
- The authors of the article cited above respond (2007) (0)
- Consensus document of Academy of Emergency Medicine and Care, Italian Committee for Standardization of Hematology and Laboratory Methods, SIBioC-Laboratory Medicine and Italian Society of Laboratory Medicine on D-dimer testing for suspected venous thromboembolism in emergency departments. (2014) (0)
- Continuation of the international standard thromboplastin (human, recombinant, plain) by means of a replacement reconstitution fluid (2008) (0)
- Thrombin Generation Test in Patients with Hemophilia and Inhibitors Treated with by-Passing Agents: Results From In Vivo Studies (2011) (0)
- Anti-phosphatidylserine/prothrombin antibodies: an additional diagnostic marker for APS? (2013) (0)
- Assessment of hypercoagulability in patients with cushing syndrome before and after surgical cure (2020) (0)
- OC-15 - Risk factors for cancer development after idiopathic venous thromboembolism. (2016) (0)
- The Coagulopathy of Chronic Liver Disease. Is the Long and Widely Held Belief Being Dispelled (2010) (0)
- P180 Increased Thrombin Generation in Inflammatory Bowel Diseases (2008) (0)
- Poor Agreement between Commercially Available Anti-Cardiolipin and Anti-β2glycoprotein I IgG and IgM Solid Phase Assays Hampers Uniformity in the Classification of Antiphospholipid Syndrome Patients (2017) (0)
- Thrombopoietin receptor agonists before elective invasive procedures in cirrhotic patients with thrombocytopenia: ready to start? (2021) (0)
- PM Exposure Increases Coagulation Function. A Study Among Highly Exposed Steel Workers in Italy (2008) (0)
- Coagulation abnormalities in patients with klinefelter syndrome compared to age-matched healthy controls: Cross-sectional assessment by thrombin generation test (2020) (0)
- Risk of relapse after SARS-CoV-2 vaccine in the Milan cohort of thrombotic thrombocytopenic purpura patients. (2023) (0)
- Factor VIII/protein C and not ADAMTS13/VWF:Ag ratio is a prognostic risk factor for patients with cirrhosis and low MELD score (2020) (0)
- Increased plasma levels of Von Willebrand factor (VWF) and Factor VIII (FVIII) during acute bacterial infection drive a pro-hemostatic imbalance and herald severe outcome in cirrhosis (2016) (0)
- Corrigendum to “Statins decrease thrombin generation in patients with hypercholesterolemia” [Eur J Intern Med 25(5), 449-451] (2015) (0)
- Over-expression of beta antithrombin in familial antithrombin deficiency caused by an ASN135 to THR mutation (1997) (0)
- Increased Plasma Levels of Von Willebrand Factor and Factor VIII (FVIII) During Acute Bacterial Infection Drive a Pro-Hemostatic Imbalance and Herald Severe Outcome in Cirrhosis (2016) (0)
- Effects of metal-rich air particles on DNA methylation and on coagulation function among foundry workers in Italy (2011) (0)
- Extracellular histones affect blood coagulation in subjects exposed to metal-rich air particles (2011) (0)
- Exposure assessment 1 (2007) (0)
- Coagulation imbalance is associated with hepatic fibrosis and vascular complications in patients with type2 diabetes and NAFLD (2022) (0)
- Comparison of Commercial ELISA Methods for the Measurement of Prothrombin Fragment 1 + 2 - Rebuttal (1995) (0)
- Primary care Reliability of international normalised ratios from two point of care test systems: comparison with conventional methods (2003) (0)
- Procoagulant imbalance in patients with non-cirrhotic chronic hepatitis C (CHC) improves six months after eradication with direct-acting antiviral agents (DAAs) and likely correlates with liver fibrosis (2020) (0)
- Antithrombotic Therapy and Liver Disease (2021) (0)
- Screening for congenital coagulation disorders (1989) (0)
- Chromogenic substrates for activated partial thromboplastin time testing: Are they worth using? (1989) (0)
- Delocalised patient testing for controling oral anticoagulant therapy (1998) (0)
- Resistance to thrombomodulin is associated with de novo portal vein thrombosis and could be a modifiable factor to improve prognosis in cirrhosis (2014) (0)
- TIPS in hereditary hemorrhagic telangiectasia: Never say never (2008) (0)
- [Natural anticoagulants as a cause of hereditary familial thrombosis]. (1990) (0)
- Patients with chronic liver disease. Are they naturally anticoagulated? (2022) (0)
- Consensus document of Italian Federation of Thrombosis Services (FCSA), Italian Society of Laboratory Medicine (SIMeL), SIBioC e Italian Committee for Standardization of Laboratory Tests (CISMEL) on laboratory monitoring of the therapy with novel oral anticoagulant drugs. (2013) (0)
- Regular Article Measurement of warfarin in plasma by high performance liquid chromatography (HPLC) and its correlation with the international normalized ratio (2003) (0)
- Study of the thrombin generation in patients with liver cirrhosis (2005) (0)
- Coagulation balance and liver damage in non-cirrhotic patients with chronic hepatitis C after eradication by Direct-acting Antiviral Agents (DAAs) (2021) (0)
- General Aspects of Sepsis-Associated Coagulopathy (2021) (0)
- Impact of von Willebrand factor and ADAMTS-13 on the pro-coagulant imbalance of patients with cirrhosis (2017) (0)
- Cirrhosis. What are all those factor VIII and protein C for? (2022) (0)
- Impact of von Willebrand factor/ADAMTS-13 on the pro-coagulant imbalance detected in cirrhosis (2017) (0)
- The non-vitamin K antagonist oral anticoagulants and heparin-induced prolongation of the activated coagulation time. (2022) (0)
- FRI-256-Procoagulant imbalance in chronic hepatitis C and its relationship with cardiovascular and liver damage (2019) (0)
- Reply to: Is platelet transfusion necessary in cirrhotic patients with splenomegaly? (2014) (0)
- PO-33 D-dimer testing to determine duration of anticoagulation and risk of occult cancer after a first episode of idiopathic venous thromboembolism: the extended follow-up of the PROLONG study (2010) (0)
- Pro-coagulant imbalance in patients with Cushing disease detected by thrombin generation assay is associated with increased levels of neutrophil extracellular trap-related factors (2016) (0)
- Calibration of the proposed 4 th International Standard for Thromboplastin, human, recombinant, plain (08/144) (2009) (0)
- Subjects Index, Vol. 26, Supplement 4, 1996 (1996) (0)
- Laying the foundations for gene therapy in Italy for patients with haemophilia A: A Delphi consensus study (2022) (0)
- Antiphospholipidsyndrome:laboratorydetection,mechanisms ofactionandtreatment (2011) (0)
- Thrombin Generation Assay Is Not Able to Predict Hemostatic Efficacy of by-Passing Agents in Patients with Hemophilia and Inhibitors: Results From in Vivo Studies (2012) (0)
- COST-EFFECTIVENESS OF COMPUTER-ASSISTED ANTICOAGULANT DOSAGE CLINICAL STUDY (2007) (0)
- PA.145 INCREASED THROMBIN GENERATION IN INFLAMMATORY BOWEL DISEASES (2008) (0)
- Anticoagulation does not increase portal hypertension related bleeding, but exposes patients with cirrhosis to a high risk of minor hemorrhages: Results from a comparative cohort study (2015) (0)
- Should We Be Concerned About Coagulation in the Treatment of Acute Variceal Hemorrhage (2014) (0)
- Impact of a commercially available DOAC absorbent on two integrated procedures for lupus anticoagulant detection in plasma containing argatroban (2022) (0)
- Procoagulant imbalance in chronic hepatitis C and its relationship with cardiovascular and liver damage (2019) (0)
- Title Page / Table of Contents / Preface (2003) (0)
- P0166 : Anticoagulation does not increase portal hypertension related bleeding, but exposes patients with cirrhosis to a high risk of minor hemorrhages. Results from a comparative cohort study (2015) (0)
- Evaluation of a method for ISI calibration of two point-of-care test (POCT) prothrombin time (PT) monitor systems (CoaguChek Mini and TAS PT-NC) with fresh plasmas based on whole blood equivalent PT (2002) (0)
- An International Normalized Ratio (INR) calibration model that is too simple leads to bias and overestimated accuracy of INR values: reply to a rebuttal (2007) (0)
- Response to Portal vein thrombosis after hepatitis C eradication with direct acting antiviral therapy. (2018) (0)
- Is umbilical cord blood a reliable source for the evaluation of neonatal hemostasis 1 at birth ? 2 (2020) (0)
- P464 RESISTANCE TO THROMBOMODULIN IS ASSOCIATED WITH DE NOVO PORTAL VEIN THROMBOSIS AND COULD BE A MODIFIABLE FACTOR TO IMPROVE PROGNOSIS IN PATIENTS WITH CIRRHOSIS (2014) (0)
- Thrombin Generation Assay During Orthopaedic Surgery In Hemophilia A With and Without Inhibitors: Results From In Vivo Studies (2013) (0)
- GENOMIC DNA METHYLATION ALTERATIONS DUE TO METAL-RICH AIR PARTICLE EXPOSURE: POTENTIAL LINKS WITH INFLAMMATION AND COAGULATION MARKERS (2011) (0)
- Procoagulant imbalance in male hypogonadism and effect of short-term testosterone replacement therapy (2022) (0)
- The Identification of High Risk APS Patients for Thrombosis with Triple Antiphospholipid Antibody Positivity Is Platform Dependent (2017) (0)
- Thromboplastin calibration revisited to look for possible revision of the World Health Organization recommendations. (2022) (0)
- Title Page / Table of Contents, Vol. 26, Supplement 4, 1996 (1996) (0)
- [The d-glucaric acid test in the evaluation of the inductive properties of phenobarbital and spironalactone]. (1974) (0)
- Global coagulation tests to assess the value of the presurgical treatment in a patient with congenital factor XI deficiency and inhibitor (2020) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Armando Tripodi?
Armando Tripodi is affiliated with the following schools:
